Crispr Therapeutics Ag (CRSP)

EBITDA Margin

-1085.51%

Quarterly · Period ending:

CRSP logo

CRSP EBITDA Margin

Latest reported-1085.51%
CRSP Quarterly EBITDA Margin (0.00% → -1085.51%)
High-resolution chart · PNG

CRSP ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag EBITDA Margin — Quarterly
Period endingEBITDA Margin
-1,085.5122%
-8,077.7092%
-14,390.9722%
-11,404.8369%
-22,713.9013%
-15,046.3584%
-90.7686%
-13,343.3555%
-23,264.2166%
-22,030.5556%
47.24%
0%
-102.6514%
-46.694%
-1,903,416.6667%
-180,963.8298%
-109,143.6709%
-95,264.0449%
-1,029.0255%
-37,210.9422%
85.2054%
-55,360.396%
-28,431.0811%
-60,854.0541%
-178,402.2727%
-45,538.2166%
16.12%
66.2706%
-16,913.522%
-14,515.5488%
-44,379.1304%
-8,623.2682%
-3,347.5184%
-1,927.1723%
5.5004%
-954.2522%
-575.0977%
-740.8065%
-976.8771%
-932.7954%
-2,137.4843%
-2,456.3025%
-4,881.7814%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.